LINDA BADDOUR

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cryoport, Inc.

Filing Date Source Excerpt
2021-03-16 Ms. Baddour is an experienced senior executive with over twenty years of experience across healthcare, life sciences and pharmaceuticals. Ms. Baddour has served on the board of directors of Waters Corporation (NYSE: WAT), a publicly traded analytical laboratory instrument and software company, since 2018, as well as Genstar Capital portfolio companies, Advarra, since 2019, and Signant Health, since 2020. From 2007 to 2018, Ms. Baddour served as Executive Vice President and Chief Financial Officer of PRA Health Sciences, Inc., a global contract research organization and data science company.
2022-03-18 Ms. Baddour is an experienced senior executive with over twenty years of experience across healthcare, life sciences and pharmaceuticals. She has served on boards of analytical laboratory instrument and software company Waters Corporation, but no direct programming or software engineering skills are indicated.
2023-03-31 Ms. Baddour is an experienced senior executive with over twenty years of experience across healthcare, life sciences and pharmaceuticals. Ms. Baddour has served on the board of directors of Waters Corporation (NYSE: WAT), a publicly traded analytical laboratory instrument and software company, since 2018, and Signant Health, since 2020. Ms. Baddour also served on the board of directors of Advarra, a Genstar Capital portfolio company, from 2019 until its sale in 2022. From 2007 to 2018, Ms. Baddour served as Executive Vice President and Chief Financial Officer of PRA Health Sciences, Inc., a global contract research organization and data science company. During Ms. Baddour’s tenure, PRA Health Sciences grew from approximately 3,000 employees to over 17,000. From 1995 to 2007, Ms. Baddour worked at Pharmaceutical Product Development, Inc., a contract research organization, serving in various roles, including as Chief Financial Officer, Treasurer and Chief Accounting Officer. Ms. Baddour earned both a B.A. and M.B.A. from the University of North Carolina at Wilmington, and is a certified public accountant.
2024-04-03 Ms. Baddour is an experienced senior executive with over twenty years of experience across healthcare, life sciences and pharmaceuticals. Ms. Baddour has served on the board of directors of Waters Corporation (NYSE: WAT), a publicly traded analytical laboratory instrument and software company, since 2018, and Signant Health, since 2020. Ms. Baddour also served on the board of directors of Advarra, a Genstar Capital portfolio company, from 2019 until its sale in 2022. From 2007 to 2018, Ms. Baddour served as Executive Vice President and Chief Financial Officer of PRA Health Sciences, Inc., a global contract research organization and data science company. During Ms. Baddour’s tenure, PRA Health Sciences grew from approximately 3,000 employees to over 17,000. From 1995 to 2007, Ms. Baddour worked at Pharmaceutical Product Development, Inc., a contract research organization, serving in various roles, including as Chief Financial Officer, Treasurer and Chief Accounting Officer. Ms. Baddour earned both a B.A. and M.B.A. from the University of North Carolina at Wilmington, and is a certified public accountant.

WATERS CORP /DE/

Filing Date Source Excerpt
2019-04-04 Ms. Baddour, 60, has served as a Director of the Company since September 2018. From June 2007 to September 2018, Ms. Baddour served as Executive Vice President and Chief Financial Officer of PRA Health Sciences. Ms. Baddour's extensive experience as a senior financial executive provides the Waters Board with significant accounting, finance and health care industry expertise. Waters Committee Memberships: Audit Committee. Director Compensation Fiscal Year 2018: Linda Baddour Fees Earned or Paid in Cash $24,333, Stock Awards $54,972, Option Awards $54,981, Total $134,286.
2020-04-02 Linda Baddour Director since 2018 Age: 61 Committees •  Audit ...Ms. Baddour’s extensive experience as a senior financial executive provides the Waters Board with significant accounting, finance, and health care industry expertise. ...Director Compensation Fiscal Year 2019 Linda Baddour Fees Earned or Paid in Cash ($): $79,000 Stock Awards ($): $109,863 Option Awards ($): $110,000 Total ($): $298,863.
2021-04-01 Linda Baddour Director since 2018 Age: 62 Committees Audit (Chair) (effective May 11, 2021), Finance ... Director Compensation Fiscal Year 2020 Linda Baddour Fees Earned or Paid in Cash $84,350 Stock Awards $109,773 Option Awards $109,941 Total $304,064
2022-04-14 Linda Baddour Director since 2018 Age: 63 Committees •  Audit (Chair) •  Finance ...The table below summarizes the compensation for the Company’s non-employee Directors in the last fiscal year. Dr. Batra did not receive any compensation for his service as a director during 2021. ...Director Compensation Fiscal Year 2021 Name Fees Earned or       Paid in Cash ($)       Stock Awards ($)         Option Awards ($)         Total ($) Linda Baddour $94,560       $109,816       $109,931       $314,307
2023-04-13 Linda Baddour Independent Director since 2018 Committees •  Audit (Chair) •  Finance In 2022, Ms. Baddour received $115,000 in fees, $109,742 in stock awards, and $109,899 in option awards, totaling $334,641.
2024-04-12 Linda Baddour Former Executive Vice President and Chief Financial Officer, PRA Health Sciences Independent Director since 2018 Age: 65 COMMITTEES • Audit & Finance (Chair)

Data sourced from SEC filings. Last updated: 2026-02-03